Pharmafile Logo

Breakthrough Prize in Life Sciences

- PMLiVE

Innate Pharma and AstraZeneca take monalizumab into phase 3

AZ hopes to catch up to rivals using the French biotech's candidate

Report: Customer experience, shaping digital healthcare

In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...

Blue Latitude Health

People with blue dots

Can you survive without the blue dot?

Or has the digital world has replaced our brain

Page & Page and Partners

- PMLiVE

Acceleron scraps rare muscular dystrophy drug

Clinical profile not strong enough to push into late-stage testing

- PMLiVE

Sumitomo Dainippon goes big on biotech with $3bn Roivant deal

Could acquire up to 11 Roivant spinouts

armadillo in chains

Should there be a punishment?

I mean for people who use the word innovation willy-nilly.Is it just us here at P&P, or has the word lost its meaning? Dictionaries define it as a new idea...

Page & Page and Partners

- PMLiVE

Chi-Med cues up two more regulatory filings in cancer

Hong Kong based firm reports strong sales in first marketed product

- PMLiVE

Biogen grows in Q2, but Spinraza performance a concern

Company banking on pipeline readouts and Tecfidra defence

Diagnosing the lag in neuropsychiatric treatments

The number of mental health research programmes in larger drug firms has shrunk by 70% in the past decade. Blue Latitude Health Senior Associate Consultant Sana Rahim explores this drop...

Blue Latitude Health

MIT reveals new pill to deliver insulin

A new MIT research project, sponsored by Novo Nordisk, is aiming to deliver insulin orally with a pill that releases medicine in the stomach lining. Dina Patel interviews the team...

Blue Latitude Health

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links